PMX-30063 - 2012 pmx-30063 london,drawback of Polymedix compound PMX 30063

PMX-30063

Get up-to-date PMX-30063 news as well as PMX-30063 related headlines such as:PMX-30063,2012 pmx-30063 london,drawback of Polymedix compound PMX 30063 etc. Keep touch with the frequently updated news about PMX-30063 to get detail information.

PMX-30063: News Headlines

• PolyMedix Initiates Dosing in Phase I Clinical Study of Novel Systemic Antibiotic Compound

  By Janet Vasquez on August 21, 2008 - PMX-30063 The First and Only Defensin Mimetic Systemic Antibiotic Drug In Human Clinical Trials ... [+]

  Read more
        Antibiotic       CLINICAL TRIALS       PMX-30063       Polymedix

• PolyMedix Announces Positive Phase I Clinical Data with PMX-30063 Novel Antibiotic Drug Candidate

  By Janet Vasquez on December 10, 2008 - First Ever Clinical Study With A Small Molecule Mimetic Of Host Defense Proteins ... [+]

  Read more
        antibiotics       host defense proteins       mimetics       Polymedix

• PolyMedix to Present Antibiotic Data at the 50th Interscience Conference on Antimicrobial Agents...

  By Janet Vasquez on September 8, 2010 - Five Poster Presentations with Results from Antimicrobial Studies Including PolyMedix’s Phase 1B Clinical Trial with PMX-30063 ... [+]

  Read more
  Antibiotic       bacteria       compound       drugs       infectious disease       Polymedix       resistance

PMX-30063: All News

All news and headlines about PMX-30063. Browse news on PMX-30063 by date to get detailed information.

• PolyMedix Initiates Dosing in Phase I Clinical Study of Novel Systemic Antibiotic Compound

  By Janet Vasquez on August 21, 2008 - PMX-30063 The First and Only Defensin Mimetic Systemic Antibiotic Drug In Human Clinical Trials ... [+]

  Read more
        Antibiotic       CLINICAL TRIALS       PMX-30063       Polymedix

• PolyMedix to Present Antibiotic Data at the 50th Interscience Conference on Antimicrobial Agents...

  By Janet Vasquez on September 8, 2010 - Five Poster Presentations with Results from Antimicrobial Studies Including PolyMedix’s Phase 1B Clinical Trial with PMX-30063 ... [+]

  Read more
  Antibiotic       bacteria       compound       drugs       infectious disease       Polymedix       resistance

• PolyMedix Announces Positive Phase I Clinical Data with PMX-30063 Novel Antibiotic Drug Candidate

  By Janet Vasquez on December 10, 2008 - First Ever Clinical Study With A Small Molecule Mimetic Of Host Defense Proteins ... [+]

  Read more
        antibiotics       host defense proteins       mimetics       Polymedix

PMX-30063

Here Free-Press-Release.com delivers top news on PMX-30063. You can get the freshest information from total 3 news.